about
sameAs
Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promotersRegulation of cadherin stability and turnover by p120ctn: implications in disease and cancerMonoclonal antibodies to DIPA: a novel binding partner of p120-catenin isoform 1Selection of monoclonal antibodies against 6-oxo-M(1)dG and their use in an LC-MS/MS assay for the presence of 6-oxo-M(1)dG in vivo.p120-catenin is essential for terminal end bud function and mammary morphogenesis.Dim1p is required for efficient splicing and export of mRNA encoding lid1p, a component of the fission yeast anaphase-promoting complexThe molecular evolution of the p120-catenin subfamily and its functional associations.ReCLIP (reversible cross-link immuno-precipitation): an efficient method for interrogation of labile protein complexes.Kinetics of lung tissue factor expression and procoagulant activity in bleomycin induced acute lung injury.The PCH family protein, Cdc15p, recruits two F-actin nucleation pathways to coordinate cytokinetic actin ring formation in Schizosaccharomyces pombeRegulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor.Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho.p120 serine and threonine phosphorylation is controlled by multiple ligand-receptor pathways but not cadherin ligation.Providing Experiential Business and Management Training for Biomedical Research Trainees.Antibody Research Group.p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia.Using Small Case-Based Learning Groups as a Setting for Teaching Medical Students How to Provide and Receive Peer Feedback.Characterizing Antibodies.Isotype Determination of Rodent-Derived Monoclonal Antibodies Using Sandwich ELISA.Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus GlycoproteinAnalysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus NeutralizationSurvey on Scientific Shared Resource Rigor and ReproducibilityEctonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic β Cells for In Vitro and In Vivo AnalysisThe Perfect Antibody: Does it Exist and How Do You Find It?ARG: The Perfect Antibody: Does it Exist and How Do You Find It?Implementing Label-free Biomolecular Interaction Analyses in an Antibody and Protein Core SettingHuman monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against diseaseIntegrated technology platform for accelerated discovery of antiviral antibody therapeuticsRapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinPotently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals
P50
Q24306506-603158C7-6E31-4E6E-ADA9-392CFB2B524FQ28294841-66E0C675-2887-42DF-8E84-6ED71E4253C1Q30417899-AC00843E-37BA-4109-8C24-DB395D3539D7Q30428229-72D7C244-8165-4967-9EDE-DD7C8892F6D7Q30513454-8A3FCC95-D81F-4BAF-B90A-2369717941E8Q33770574-30A5A686-8CC3-4ABF-8F59-B2704EDDC3E8Q33786720-10D502AA-8D3F-4BA8-AA6A-13FF0FE56E6FQ33809330-7AAE8805-CDA1-43E8-B14E-F901F846BA9AQ35829051-3CDECF5E-9AC5-41EB-9C95-D47C15B514C1Q36323291-B55ED6BF-DE13-4718-A291-FEED088E7011Q36549153-CE759BD5-D941-4FC3-9A38-44F4F9B9F9A8Q38727221-372E1ACA-52D7-45A4-A025-9F153DB91A13Q40203974-F67DC1A6-30E5-447F-9B40-8A28C1779D04Q40239203-99FD1A05-E9A6-44BA-AB4B-8B20B27DF5A7Q41559755-BA0649AC-83B7-42AB-AB97-560AB24A6DC8Q46509402-2CF0F70F-346E-49EB-8665-1C8DF3F224BDQ47609252-2350DC7A-8BD6-4139-80E0-BC55C03B2AA8Q47736605-73A8EDAB-8941-4AB0-97F5-9D46130F4883Q50221364-4949E267-29E3-4480-BE41-8A55518A8785Q52838015-820CE274-5698-40FA-9D4C-22964891A88BQ56897586-ACF161C6-AED2-4E45-ADCF-D125764A9533Q89548894-E1A61BB3-9D39-463F-B860-26FDFE7FF2F3Q92889455-1A4F1A04-72EB-484C-8D89-E8A0559A9353Q93200106-E16D92E4-049F-43F0-B1D3-1874837E4664Q93579949-B2C07235-77AD-405C-85EE-2BABD5D9BF7AQ93580097-C7826FB4-02EE-400A-A2B0-C28CF22F204CQ93580134-BF9B2B09-451A-4B6D-9739-633C19B44665Q94512392-F8A0559B-A661-47C1-B78A-B809B00DDE96Q95601420-AB6ABD60-33EA-4DD5-B204-981DDC0CF632Q95627204-91B6D8FB-9BC5-46C7-8FDA-D0676AC761D9Q96223435-168AD8FF-8B53-461D-8952-D797F65E4A4F
P50
description
pediatric medical researcher
@en
wetenschapper
@nl
name
Robert H. Carnahan
@en
Robert H. Carnahan
@es
Robert H. Carnahan
@nl
type
label
Robert H. Carnahan
@en
Robert H. Carnahan
@es
Robert H. Carnahan
@nl
altLabel
Robert Carnahan
@en
prefLabel
Robert H. Carnahan
@en
Robert H. Carnahan
@es
Robert H. Carnahan
@nl
P101
P108
P21
P31
P496
0000-0001-5230-1532